The Week in Swiss Startups (29.05-02.06.2023) - Week #22
The fifth week of May ‘23 features 8 startups and 1 exit. Teylor raises €275M. Is 2023 the year of bridge rounds?
Hi there!
the Swiss fintech startup Teylor made headlines last week by securing €275M in funding through a combination of debt and equity. This significant financial round has caught the attention of many in the industry. In other Swiss news, the past week was relatively calm.
However, I stumbled upon a noteworthy LinkedIn post by Peter Walker, the Head of Insights at Carta:
VC funds raised record amounts in 2021 and early 2022. And yes, that capital will be deployed (eventually). But the expected deluge of cash into venture is likely to appear more like a drip. 2023 is the year of bridge rounds.
Do you agree with that statement?
I highly recommend following him for interesting insights on topics such as financing rounds, valuations, and much more.
Wishing you a fantastic week ahead!
Gian
P.S.: Do you want to support/sponsor the weekly newsletter? Discover your options here!
AI/ML - B2B SaaS
Calvin Risk: Undisclosed - Second tranche pre-seed
RefFIT: CHF 40k - Convertible Loan
Biotech
Adaptyv Bio: CHF 100k - Loan
Trojan Therapeutics: CHF 40k - Convertible Loan
Cleantech
Callirius: CHF 1.5M - Pre-seed
Hexem: CHF 100k - Loan
Engineering
Synthara: CHF 100k - Award
Fintech
Teylor: €275 - Debt + Equity
—
Exit
Abiogen Pharma acquires EffRx Pharmaceuticals
—
Swisspreneur Podcast
Listen to Alexander Ciritsis, co-founder and CTO at b-rayZ: Medtech AI for Early Cancer Detection - EP #323
—